PATENT CLAIM ANALYSIS

Application Number: 16068553
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "338000"]

Abstract:
The present invention provides a prophylactic or therapeutic agent for an autism spectrum disorder containing compound (I) having melatonin receptor affinity. A compound represented by the formula: wherein each symbol is as described in the specification, or a salt thereof.

Claim (Index 6):
(S)\u2014N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]acetamide or a salt thereof for use in the prophylaxis or treatment of an autism spectrum disorder.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 95.0
- Lexical Diversity: 1.12195
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14017819', '13657956', '11887368', '13047409', '13047363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8222190882121408
- 35 USC 102 Novelty (BERT): 0.5736843973819925
- Combined Prediction Score: 0.7973656191291261
- Mean Citation Score: 398.583552
- Max Citation Score: 481.32886
- Similarity Product: 390.7318967207611

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test